Phase I, open-label, dose-escalation study of AZD7762 in combination with irinotecan (irino) in patients (pts) with advanced solid tumors Meeting Abstract


Authors: Ho, A. L.; Bendell, J. C.; Cleary, J. M.; Schwartz, G. K.; Burris, H. A.; Oakes, P.; Agbo, F.; Barker, P. N.; Senderowicz, A. M.; Shapiro, G.
Abstract Title: Phase I, open-label, dose-escalation study of AZD7762 in combination with irinotecan (irino) in patients (pts) with advanced solid tumors
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880301462
PROVIDER: wos
DOI: 10.1200/jco.2011.29.15_suppl.3033
Notes: Meeting Abstract: 3033 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Alan Loh Ho
    213 Ho